Bionote IPO Trading - Weakest Demand Even After Cutting Price and Size
Bionote (377740 KS) raised US$72.2m in its Korean IPO. In this note, we will talk about the demand for the deal and other trading dynamics.
698 Views
Bionote: IPO Price Reduced Significantly & Bookbuilding Results
Bionote slashed its IPO price to 9,000 won, a 50% lower than the low end of IPO range. Our base case valuation is lowered to 12,741 won per share,...
396 Views
ECM Weekly (4th Dec 2022) - Skymark, Daiei, Sunshine, Lygend, Weilong, NRI, Zomato, Goto, Bobcat
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
449 Views
Bionote IPO - Delayed Timeline & Updated Valuation Analysis
Our updated base case valuation is target price of 16,966 won per share, which is 6% lower than the low end of the IPO price range.
331 Views
ECM Weekly (13th Nov 2022) - I-Tail, Blibli, Nykaa, PB Fin, Five Star, Archean, GDRs, Axis Bank
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
453 Views